Patricia Sullivan

1.3k total citations
24 papers, 849 citations indexed

About

Patricia Sullivan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Patricia Sullivan has authored 24 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Patricia Sullivan's work include Cancer therapeutics and mechanisms (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Emergency and Acute Care Studies (2 papers). Patricia Sullivan is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Emergency and Acute Care Studies (2 papers). Patricia Sullivan collaborates with scholars based in United States and Canada. Patricia Sullivan's co-authors include J. J. Mahany, Robert H. Vonderheide, Kelli L. Running, Scott Antonia, Richard D. Huhn, Magi Khalil, Peter J. O’Dwyer, Natalie A. Hutnick, Keith T. Flaherty and David L. Bajor and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Patricia Sullivan

24 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Sullivan United States 11 410 361 149 138 66 24 849
P. Y. Liu United States 12 362 0.9× 292 0.8× 242 1.6× 39 0.3× 71 1.1× 18 712
Timothy Clay Australia 18 637 1.6× 464 1.3× 309 2.1× 177 1.3× 60 0.9× 84 1.2k
Corien Eeltink Netherlands 17 376 0.9× 102 0.3× 148 1.0× 63 0.5× 40 0.6× 40 848
Laurie Tuason United States 16 467 1.1× 221 0.6× 149 1.0× 333 2.4× 38 0.6× 27 1.1k
Shiann‐Tarng Jou Taiwan 24 355 0.9× 357 1.0× 516 3.5× 122 0.9× 62 0.9× 118 1.9k
Melinda A. Merrell United States 15 294 0.7× 348 1.0× 197 1.3× 131 0.9× 56 0.8× 37 1.1k
Elaine Chang United States 15 292 0.7× 71 0.2× 92 0.6× 144 1.0× 62 0.9× 47 781
Ibtissam Youlyouz‐Marfak Morocco 14 155 0.4× 128 0.4× 136 0.9× 65 0.5× 21 0.3× 38 695
Mary Ellen Ross United States 13 250 0.6× 563 1.6× 157 1.1× 32 0.2× 30 0.5× 34 1.1k
Anne Rigg United Kingdom 13 379 0.9× 76 0.2× 209 1.4× 159 1.2× 47 0.7× 37 971

Countries citing papers authored by Patricia Sullivan

Since Specialization
Citations

This map shows the geographic impact of Patricia Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Sullivan more than expected).

Fields of papers citing papers by Patricia Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Sullivan. The network helps show where Patricia Sullivan may publish in the future.

Co-authorship network of co-authors of Patricia Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Sullivan. A scholar is included among the top collaborators of Patricia Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Sullivan. Patricia Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Green-McKenzie, Judith, Frances S. Shofer, Florence Momplaisir, et al.. (2021). Factors Associated With COVID-19 Vaccine Receipt by Health Care Personnel at a Major Academic Hospital During the First Months of Vaccine Availability. JAMA Network Open. 4(12). e2136582–e2136582. 23 indexed citations
2.
Aysola, Jaya, Justin T. Clapp, Patricia Sullivan, et al.. (2021). Understanding Contributors to Racial/Ethnic Disparities in Emergency Department Throughput Times: a Sequential Mixed Methods Analysis. Journal of General Internal Medicine. 37(2). 341–350. 13 indexed citations
3.
Sullivan, Patricia, et al.. (2019). Using Multi-Disciplinary Design Challenges to Enhance Self-Efficacy within a Summer STEM Outreach Program. Texas Digital Library (University of Texas). 3 indexed citations
4.
Simmons, W. Michele, et al.. (2017). Lean Technical Communication: Toward Sustainable Program Innovation. 2 indexed citations
5.
Triplett, Patrick, et al.. (2017). The Milieu Manager: A Nursing Staffing Strategy to Reduce Observer Use in the Acute Psychiatric Inpatient Setting. Journal of the American Psychiatric Nurses Association. 23(6). 422–430. 6 indexed citations
6.
Luu, Minnelly, Susan L. Boone, Jyoti D. Patel, et al.. (2011). Higher severity grade of erlotinib-induced rash is associated with lower skin phototype. Clinical and Experimental Dermatology. 36(7). 733–738. 17 indexed citations
7.
Vonderheide, Robert H., Keith T. Flaherty, Magi Khalil, et al.. (2007). Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody. Journal of Clinical Oncology. 25(7). 876–883. 416 indexed citations
8.
Münster, Pamela N., Douglas C. Marchion, Elona Biçaku, et al.. (2005). Phase I trial of the histone deacetylase inhibitor, valproic acid and the topoisomerase II inhibitor, epirubicin: A clinical and translational Study. Journal of Clinical Oncology. 23(16_suppl). 3084–3084. 8 indexed citations
9.
Hausheer, F. H., Elmer Berghorn, Daniel M. Sullivan, et al.. (2004). Phase II trial of karenitecin (BNP1350) in malignant: Clinical and translational study. Journal of Clinical Oncology. 22(14_suppl). 7554–7554. 1 indexed citations
10.
Sullivan, Patricia, et al.. (2003). A laparoscopic approach to small bowel obstruction secondary to endometriosis. Surgical Endoscopy. 17(10). 1678–1679. 4 indexed citations
11.
Sullivan, Patricia. (1999). Sugar and Spice vs. Snips and Snails.. 24(8). 8–12. 1 indexed citations
12.
Sullivan, Patricia, et al.. (1999). Sick-child daycare promotes healing and staffing.. PubMed. 30(4). 46–7. 11 indexed citations
13.
Sullivan, Patricia. (1998). Empty Nest Syndrome.. 23(9). 32–33. 8 indexed citations
14.
Sullivan, Patricia. (1998). The PTA's National Standards.. Educational leadership. 55(8). 43–44. 4 indexed citations
15.
Ballester, Oscar, Lynn C. Moscinski, Karen K. Fields, et al.. (1997). Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC‐IE): a novel, intensive induction chemotherapy regimen for patients with high‐risk multiple myeloma. British Journal of Haematology. 96(4). 746–748. 10 indexed citations
16.
Bryanton, Janet, et al.. (1994). Women's Perceptions of Nursing Support during Labor. Journal of Obstetric, Gynecologic & Neonatal Nursing. 23(8). 638–644. 59 indexed citations
17.
Sullivan, Patricia, et al.. (1993). Asbestos screening and education programs for building and construction trades unions. American Journal of Industrial Medicine. 23(1). 143–152. 4 indexed citations
18.
Mittelman, Abraham, Carmelo Puccio, Honggu Chun, et al.. (1990). Phase II trial of fludarabine phosphate (F-ara-AMP) in patients with advanced head and neck cancer. Investigational New Drugs. 8(S1). S65–S67. 6 indexed citations
19.
Gottlieb, Jeffrey A., Robert S. Benjamin, Laurence H. Baker, et al.. (1976). Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(2). 199–203. 114 indexed citations
20.
Samuels, M. L., Patricia Sullivan, & Clifton D. Howe. (1968). Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma). Cancer. 22(3). 525–532. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026